Foghorn Therapeutics (FHTX) PT Lowered to $23 at Morgan Stanley

March 22, 2021 9:34 AM EDT
Get Alerts FHTX Hot Sheet
Price: $11.92 -2.38%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 18 | Down: 8 | New: 31
Trade Now! 
Join SI Premium – FREE
Morgan Stanley analyst Vikram Purohit lowered the price target on Foghorn Therapeutics (NASDAQ: FHTX) to $23.00 (from $24.00) while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change